NREP
NEW REPRESENTATIVE AT IB RECEIVED
18/12/2025
Voltar para busca
Dado oficial do USPTO
C CANCER RESEARCH HORIZONS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Snapshot rápido
ST13
US500000079357872Classe
1, 5, 10, 35, 36, 41, 42, 45
Pedido
79357872
Registro
7256888
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
30
Atualização mais recente
19/12/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 10, 35, 36, 41, 42, 45
Data de depósito
05/07/2022
Data de registro
02/01/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
02/01/2024
Última transação
19/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
GB
Examinador
RIEPEL,CHRISTINA MAXINE
Unidade examinadora
N60
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the literal elements "C CANCER RESEARCH HORIZONS" on a navy blue background, "CANCER RESEARCH HORIZONS" in white and "C" formed from an array of circles appearing in grey, royal blue, sky blue, and white.
Titulares e representantes
Titulares
Cancer Research Technology Limited
Representantes
David J. Hrina Brennan, Manna & Diamond, LLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10Classe 35Classe 36Classe 41Classe 42Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in the pharmaceutical researchdevelopment or manufacturing industry; chemical preparations for use in the manufacture of pharmaceuticals; cultures of cell media for scientific and research use; media for cell culture for laboratory use in the biotechnological industry; media for cell culture for use in non-medical research laboratories; media for cell culture for use in medical research laboratories
Classe 5
Pharmaceutical products for the diagnosisprevention or treatment of cancer; cultures of cell media for medical and veterinary use; living cells for medical or veterinary use
Classe 10
Medical apparatus and instrumentsnamely for the diagnosisprevention or treatment of cancer; surgical apparatus and instruments; diagnostic apparatus for medical purposes for the diagnosis or prevention of cancer
Classe 35
promotion and advertising of products and services for others for the treatment of cancer; marketing of products and services for others for the treatment of cancer; business project management; business intermediary services in the nature of connecting buyers and sellers for the sale and purchase of goods and services for the treatment of cancer; business information services; providing an on-line commercial information directory for products and services for the treatment of cancer; providing advertising information featuring goods and services of others for the treatment of cancer via an on-line searchable database; business advisory services relating to the commercialisation of products and services for the treatment of cancer
Classe 36
Charitable fundraising; Charitable collections in the nature of charitable fundraising; Organisation of charitable collections in the nature of charitable fundraising; charitable fundraising services by means of organisation of fundraising activities and events to support cancer research; providing financial grants for the purpose of researchdiagnosistreatment and prevention of cancer
Classe 41
Organisation of community sporting and cultural events; arranging and conducting of conferences and seminars in the field of cancer preventiondiagnosis and treatment; education servicesnamely coursesseminarsworkshops and conferences featuring subject matter related to alleviationdiagnosisprevention and treatment of cancer; the publication of bookstexts and magazines; developing and conducting educational programs in the fields of healthdietnutritioncancer and cancer prevention
Classe 42
Scientific and medical research services; providing medical and scientific research information relating to alleviationdiagnosisprevention and treatment of cancer; Conducting research in the fields of healthdietnutritioncancer and cancer prevention; conducting clinical trials for others in the field of oncology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; biomedical research services; laboratory research services relating to cancer and diagnosisprevention or treatment thereof; medical research in the field of oncology; scientific advisory services relating to chemical reagents; scientific advisory services relating to biological reagents; Clinical or medical laboratory services relating to the production of monoclonal antibodies; laboratory research in the field of gene expression
Classe 45
Licensing of intellectual property; licensing of intellectual property for use in the treatment of cancer
Publicações
Histórico de despachos e eventos da marca no USPTO.
30 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
30/04/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/04/2024
FIMP
FINAL DISPOSITION PROCESSED
09/04/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/04/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/01/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
02/01/2024
GPNX
NOTIFICATION PROCESSED BY IB
17/10/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17/10/2023
PUBO
PUBLISHED FOR OPPOSITION
17/10/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/09/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
27/09/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
27/09/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/09/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
08/09/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/09/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
08/09/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/09/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/08/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/08/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/08/2023
RFNT
REFUSAL PROCESSED BY IB
04/07/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/06/2023
RFRR
REFUSAL PROCESSED BY MPU
10/06/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
26/04/2023
CNRT
NON-FINAL ACTION WRITTEN
25/04/2023
DOCK
ASSIGNED TO EXAMINER
19/04/2023
MAFR
APPLICATION FILING RECEIPT MAILED
23/12/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19/12/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
17/12/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace C CANCER RESEARCH HORIZONS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.